Induction of V(D)J-mediated recombination of an extrachromosomal substrate following exposure to DNA-damaging agents

Environmental and Molecular Mutagenesis

Volumn 48, Issue 6, 2007, Pages 440-450

  Pinsonneault, Robert L ^a   Vacek, Pamela M ^b   O'Neill, J Patrick ^a,b   Finette, Barry A ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Alkylating agents; Cancer; Gamma radiation; Genotoxic exposure; V(D)J recombinase

Indexed keywords

ALKYLATING AGENT; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; METHYLSULFONE; RAG1 PROTEIN; RAG2 PROTEIN; RECOMBINASE; SULFONIC ACID DERIVATIVE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GAMMA IRRADIATION; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENOTOXICITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

BIOLOGICAL MARKERS; CELL DEATH; CELL LINE; DNA DAMAGE; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ETHYL METHANESULFONATE; GAMMA RAYS; HOMEODOMAIN PROTEINS; HUMANS; MUTAGENS; NUCLEAR PROTEINS; PLASMIDS; RECOMBINATION, GENETIC; VDJ RECOMBINASES;

EID: 34547640830     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20299     Document Type: Article

References (46)

1. Brown KD, Lataxes TA, Shangary S, Mannino JL, Giardina JF, Chen J, Baskaran R. 2000. Ionizing radiation exposure results in up-regulation of Ku70 via a p53/ataxia-telangiectasia-mutated protein-dependent mechanism. J Biol Chem 275:6651-6656.
2. Cadet J, Bellon S, Douki T, Frelon S, Gasparutto D, Muller E, Pouget JP, Ravanat JL, Romieu A, Sauvaigo S. 2004. Radiation-induced DNA damage: Formation, measurement, and biochemical features. J Environ Pathol Toxicol Oncol 23:33-43.
3. Chen C-L, Fuscoe JC, Liu Q, Relling MV. 1996. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells. Blood 88:2210-2218.
4. Chen L, Morio T, Minegishi Y, Nakada S, Nagasawa M, Komatsu K, Chessa L, Villa A, Lecis D, Delia D, Mizutani S. 2005. Ataxia-telangiectasia-mutated dependent phosphorylation of Artemis in response to DNA damage. Cancer Sci 96:134-141.
5. Chen P-L, Chen C-F, Chen Y, Xiao J, Sharp ZD, Lee W-H. 1998. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci USA 95:5287-5292.
6. Cloutier JF, Castonguay A, O'Connor TR, Drouin R. 2001. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. J Mol Biol 306:169-188.
7. Collier AC, Dandge SD, Woodrow JE, Pritsos CA. 2005. Differences in DNA-damage in non-smoking men and women exposed to environmental tobacco smoke (ETS). Toxicol Lett 158:10-19.
8. Danska JS, Pflumio F, Williams CJ, Huner O, Dick JE, Guidos CJ. 1994. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266:450-455.
9. Dobo KL, Eastmond DA, Grosovsky AJ. 1997. The influence of cellular apoptotic capacity on N-nitrosodimethylamine-induced loss of heterozygosity mutations in human cells. Carcinogenesis 18: 1701-1707.
10. Eadie JS, Conrad M, Toorchen D, Topal MD. 1984. Mechanism of mutagenesis by O6-methylguanine. Nature 308:201-203.
11. Elkin SK, Ivanov D, Ewalt M, Ferguson CG, Hyberts SG, Sun ZY, Prestwich GD, Yuan J, Wagner G, Oettinger MA, Gozani OP. 2005. A PHD finger motif in the C terminus of RAG2 modulates recombination activity. J Biol Chem 280:28701-28710.
12. Ellison KS, Dogliotti E, Essigmann JM. 1989. Construction of a shuttle vector containing a single O6-methylguanine: A probe for mutagenesis in mammalian cells. Mutat Res 220:93-100.
13. Finette BA. 2006. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children. DNA Repair (Amst) 5:1049-1064.
14. Finette BA, O'Neill JP, Vacek PM, Albertini RJ. 1998. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med 4:1144-1151.
15. Gauss GH, Lieber MR. 1993. Unequal signal and coding joint formation in human V(D)J recombination. Mol Cell Biol 13:3900-3906.
16. Gellert M, Hesse JE, Hiom K, Melek M, Modesti M, Paull TT, Ramsden DA, Gent DCv. 1999. V(D)J Recombination: Links to transposition and double-strand break repair. Cold Spring Harb Symp Quant Biol 64:161-167.
17. Gladdy RA, Taylor MD, Williams CJ, Grandal I, Karaskova J, Squire JA, Rutka JT, Guidos CJ, Danska JS. 2003. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 3:37-50.
18. Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E. 1997. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 90:4876-4885.
19. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF, Danska JS. 1996. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 10:2038-2054.
20. Hanft VN, Fruchtman SR, Pickens CV, Rosse WF, Howard TA, Ware RE. 2000. Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood 95:3589-3593.
21. John EM, Savitz DA, Sandler DP. 1991. Prenatal exposure to parents' smoking and childhood cancer. Am J Epidemiol 133:123-132.
22. Jones LK, Neat MJ, van Delft FW, Mitchell MP, Adamaki M, Stoneham SJ, Patel N, Saha V. 2003. Cryptic rearrangement involving MLL and AF10 occuring in utero. Leukemia 17:1667-1669.
23. Keohavong P, Xi L, Day RD, Zhang L, Grant SG, Day BW, Ness RB, Bigbee WL. 2005. HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy. Mutat Res 572:156-66.
24. Kruhlak MJ, Celeste A, Dellaire G, Fernandez-Capetillo O, Muller WG, McNally JG, Bazett-Jones DP, Nussenzweig A. 2006. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J Cell Biol 172:823-834.
25. Lee J, Desiderio S. 1999. Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity 11:771-781.
26. Lewis SM. 1994. The mechanism of V(D)J joining: Lessons from molecular, immunological, and comparative analyses. Adv Immunol 56:27-150.
27. Lieber MM, Hesse JE, Mizuuchi K, Gellert M. 1988. Lymphoid V(D)J recombination: Nucleotide insertion at signal joints as well as coding joints. Proc Natl Acad Sci USA 85:8588-8592.
28. Lieber MR, Ma Y, Pannicke U, Schwarz K. 2004. The mechanism of vertebrate nonhomologous DNA end joining and- its role in V(D)J recombination. DNA Repair (Amst) 3:817-826.
29. Marculescu R, Le T, Simon P, Jaeger U, Nadel B. 2002. V(D)J-mediated translocations in lymphoid neoplasms: A functional assessment of genomic instability by cryptic sites. J Exp Med 195:85-98.
30. McGregor WG, Maher VM, McCormick JJ. 1994. Kinds and locations of mutations induced in the hypoxanthine-guanine phosphoribosyltransferase gene of human T-lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase. Cancer Res 54:4207-4213.
31. Myung K, Braastad C, He DM, Hendrickson EA. 1998. KARP-1 is induced by DNA damage in a p53- and ataxia telangiectasia mutated-dependent fashion. Proc Natl Acad Sci USA 95:7664-7669.
32. NCI. 1999. Health effects of exposure to environmental tobacco smoke: The report of the California Environmental Protection Agency, Smoking and Tobacco Control Monograph No 10. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Report No. 99-4645.
33. Pastwa E, Neumann RD, Mezhevaya K, Winters TA. 2003. Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiat Res 159:251-261.
34. Perkins EJ, Nair A, Cowley DO, Van Dyke T, Chang Y, Ramsden DA. 2002. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev 16:159-164.
35. Poli P, Buschini A, Spaggiari A, Rizzoli V, Carlo-Stella C, Rossi C. 1999. DNA damage by tobacco smoke and some antiblastic drugs evaluated using the Comet assay. Toxicol Lett 108:267-276.
36. Rooney S, Chaudhuri J, Alt FW. 2004. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol Rev 200:115-131.
37. Roth DB. 2003. Restraining the V(D)J recombinase. Nat Rev Immunol 3:656-666.
38. Sandor Z, Calicchio ML, Sargent RG, Roth DB, Wilson JH. 2004. Distinct requiremetns for Ku in N nucleotide addition at V(D)J- and non-V(D)J-generated double-strand breaks. Nucleic Acids Res 32:1866-1873.
39. Sasco AJ, Vainio H. 1999. From in utero and childhood exposure to parental smoking to childhood cancer: A possible link and the need for action. Hum Exp Toxicol 18:192-201.
40. Schwartz JL, Morgan WF, Weichselbaum RR. 1985. Different efficiencies of interaction between 3-aminobenzamide and various monofunctional alkylating agents in the induction of sister chromatid exchanges. Carcinogenesis 6:699-704.
41. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GCF, Pui CH, Grosveld G, Downing JR. 1995. TEL/ AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL, defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985-1989.
42. Srinivas SK, Sixbey JW. 1995. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 69:8155-8158.
43. Tonegawa S. 1983. Somatic generation of antibody diversity. Nature 302:575-581.
44. Wagner ED, Anderson D, Dhawan A, Rayburn AL, Plewa MJ. 2003. Evaluation of EMS-induced DNA damage in the single cell gel electrophoresis (Comet) assay and with flow cytometric analysis of micronuclei. Teratog Carcinog Mutagen Suppl 2:1-11.
45. Ward JF. 2000. Complexity of damage produced by ionizing radiation. Cold Spring Harb Symp Quant Biol 65:377-382.
46. West KL, Singha NC, De Ioannes P, Lacomis L, Erdjument-Bromage H, Tempst P, Cortes P. 2005. A direct interaction between the RAG2 C terminus and the core histones is required for efficient V(D)J recombination. Immunity 23:203-212.